FDA Approval Opens Bright New Year for More TB Cocktails

The FDA's end-of-the-year approval of Janssen Therapeutics' Sirturo rang in a new year of hope for patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). And it brought good cheer to other biopharma companies developing their own cocktails intended to make the deadly form of TB toast.